The agony and the efficacy: central mechanisms of GLP-1 induced adverse events and their mitigation by GIP

Benzer Materyaller

• Secretion of glucagon, GLP-1 and GIP may be affected by circadian rhythm in healthy males
  Yazar:: Dorte B. Zilstorff, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-03-01)
• The agony and the efficacy: central mechanisms of GLP-1 induced adverse events and their mitigation by GIP
  Yazar:: Jonathan D. Douros, ve diğerleri
  Baskı/Yayın Bilgisi: (2025-02-01)
• A once-daily GLP-1/GIP/glucagon receptor tri-agonist (NN1706) lowers body weight in rodents, monkeys and humans
  Yazar:: Brian Finan, ve diğerleri
  Baskı/Yayın Bilgisi: (2025-06-01)
• Increased Body Weight and Fat Mass After Subchronic GIP Receptor Antagonist, but Not GLP-2 Receptor Antagonist, Administration in Rats
  Yazar:: Sara Baldassano, ve diğerleri
  Baskı/Yayın Bilgisi: (2019-08-01)
• GLP-1 and GIP in Type 1 Diabetes Therapy: A Time for Reappraisal?
  Yazar:: Grazia Piras, ve diğerleri
  Baskı/Yayın Bilgisi: (2026-03-01)